本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Organon & Co

8.89
-0.1100-1.22%
盤後9.010.1200+1.35%17:32 EST
成交量:470.79萬
成交額:4,217.87萬
市值:23.11億
市盈率:4.65
高:9.15
開:8.94
低:8.82
收:9.00
52周最高:17.23
52周最低:6.18
股本:2.60億
流通股本:2.59億
量比:0.95
換手率:1.82%
股息:0.34
股息率:3.82%
每股收益(TTM):1.91
每股收益(LYR):3.36
淨資產收益率:71.62%
總資產收益率:6.40%
市淨率:2.55
市盈率(LYR):2.64

資料載入中...

公司資料

公司名字:
Organon & Co
交易所:
NYSE
成立時間:
1923
員工人數:
10000
公司地址:
30 Hudson Street,Floor 33,Jersey City,New Jersey,United States
郵編:
07302
電話:
傳真:
- -
簡介:
Organon & Co.是一家特拉華州公司,成立於2020年3月11日。Organon是一家基於科學的全球製藥公司,通過一系列針對女性健康,生物仿製藥和知名品牌的處方療法,開發並提供創新的健康解決方案。他們的使命是成為世界領先的女性保健公司,每天為每個女性提供更好,更健康的服務。他們計劃利用自身在生殖健康方面的優勢,建立一系列健康解決方案,為從青春期到更年期及以後的婦女提供服務。

董事

名稱
職位
Alan Ezekowitz
Independent Director
Carrie S. Cox
Interim Executive Chair, Independent Director
Cynthia M. Patton
Independent Director
Deborah Leone
Independent Director
Grace Puma
Independent Director
Helene Gayle
Independent Director
Philip Ozuah
Independent Director
Robert Essner
Lead Independent Director
Rochelle B. Lazarus
Independent Director
Shalini Sharp
Independent Director

股東

名稱
職位
Joseph Morrissey
Executive Vice President and Head of Manufacturing and Supply, Interim Chief Executive Officer
Matthew Walsh
Executive Vice President and Chief Financial Officer
Aaron Falcione
Executive Vice President and Chief Human Resources Officer
Daniel Karp
Executive Vice President, Corporate Development
Juan Camilo Arjona Ferreira
Executive Vice President, Head of Research & Development and Chief Medical Officer
Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
Rachel Stahler
Executive Vice President and Chief Digital & Growth Officer
Vittorio Nisita
Executive Vice President and Head of Enterprise Services & Solutions